Martin Shkreli
martin@martinshkreli.com
←
|
PFE.xlsx
|
Failures
Master Pipeline
Approved Products
Management
Main
Model
Comirnaty
Ibrance
Enbrel
Paxlovid
Eliquis
Prevnar
Inlyta
Xeljanz
Chantix
Chantix Model
Lorbrena
Xalkori
Myfembree
etrasimod
elranatamab
giroctocogene
PF-06425090
VLA15
Sutent
Diflucan
Cardura
Vfend
Zyvox
Selzentry
PF868554
Aricept
Zithromax
fordadistrogene
Genotropin
Accupril
Fablyn
tanezumab
Acquisitions
IP
A
B
C
1
2
3
4
5
Pharmacia
4/1/2003
6
Esperion
2/1/2004
7
Vicuron
9/1/2005
Martin Shkreli